


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.11%
+0.19%
+0.11%
-1.71%
NWE
NorthWestern Corpora
$68.35
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
NWE Price Performance
$67.54 (+1.20%)
$65.11 (+4.98%)
$56.44 (+21.10%)
$54.85 (+24.61%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
NWE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NWE Street Sentiment is extremely bullish and have positive views on the near-term outlook
NWE has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
NEUTRAL
Date
Action
Rating
Firm
Dec 15, 2025
Upgrade
both
Dec 13, 2025
Reiterate
Neutral
JP Morgan
Oct 22, 2025
Reiterate
Overweight
Barclays
What is NWE current stock price?
What are NWE stock strengths?
What is NWE Risk Level?
What is NWE market cap and volume?
What is NWE current Stock IQ?
Should I buy NWE stock right now?
Is NWE a Strong Buy right now?
What does a 'Strong Buy' rating mean for NWE?
What does a 'Strong Sell' rating mean for NWE?
What factors influence NWE's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.11%
+0.19%
+0.11%
-1.71%
NWE
NorthWestern Corpora
Current Price
$68.35

NWE Price Performance
$67.54 (+1.20%)
$65.11 (+4.98%)
$56.44 (+21.10%)
$54.85 (+24.61%)
NWE Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
NWE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
NWE Street Sentiment is extremely bullish and have positive views on the near-term outlook
NWE has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
NEUTRAL
Dec 15, 2025
Upgrade
both
Dec 13, 2025
Reiterate
Neutral
JP Morgan
Oct 22, 2025
Reiterate
Overweight
Barclays
NWE Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
NWE Latest Analysis
Labrador Gold Signs Agreement to Form Joint Venture With Nemo Resources Through Elementary Minerals Inc for Exploration of the Watson Project in Northwestern Ontario.
Tue Feb 10, 2026
NorthWestern (NWE) Reports Next Week: Wall Street Expects Earnings Growth. NorthWestern (NWE) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wed Feb 4, 2026
CRDF: New CEO Presents Phase II Readout. By On January 27th 2026 Cardiff Oncology Inc. (NASDAQ:CRDF) announced that its CEO Dr. Mark Erlander and CFO James Levine stepped down from their roles. The new chief executive officer is Dr. Mani Mohindru who has been on Cardiffs board since 2021. the lead finance role was assumed by Brigitte Lindsay who was appointed as Chief Accounting Officer. Along with the appointment of new executives the company select data from its Phase II trial in onvansertib
Tue Feb 3, 2026
CEO Chat with Eric Schlorff CEO of SeaStar Medical Holding Corporation. . Joining me today is Mr. Eric Schlorff. Hes the CEO of SeaStar Medical Holding Corp which trades on the NASDAQ under the ticker symbol ICU. SeaStar is a commercial-stage healthcare company focused on treatments for critically ill patients facing organ failure and potential loss of life. We recently initiated coverage of SeaStar with a $12 valuation. Welcome Eric and thanks for joining me today.What the Selective Cytophereti
Mon Feb 2, 2026
NorthWestern Energy Group (NWE) Price Target Increased to $62.
Mon Feb 2, 2026
Why NorthWestern (NWE) Could Beat Earnings Estimates Again. NorthWestern (NWE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thu Jan 29, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.